The mild cognitive impairment stage of dementia with lewy bodies and Parkinson disease: A comparison of cognitive profiles

Alzheimer Disease and Associated Disorders

Volumn 28, Issue 2, 2014, Pages 151-155

  Yoon, Jung Han ^a   Lee, Ji Eun ^b   Yong, Seok Woo ^a   Moon, So Young ^a   Lee, Phil Hyu ^b  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Dementia with Lewy bodies; Lewy body disease; Mild cognitive impairment; Parkinson disease; Parkinson disease with dementia

Indexed keywords

LEVODOPA;

AGED; ARTICLE; ATTENTION; CONTROLLED ORAL WORD ASSOCIATION TEST; CONTROLLED STUDY; DEMOGRAPHY; DIFFUSE LEWY BODY DISEASE; EXECUTIVE FUNCTION; FEMALE; GO NO GO TEST; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; REY COMPLEX FIGURE TEST; SEMANTIC FLUENCY TEST; STROOP TEST; UNIFIED PARKINSON DISEASE RATING SCALE; VERBAL MEMORY; VISUAL HALLUCINATION; VISUAL MEMORY; COMPARATIVE STUDY; MEMORY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGED; EXECUTIVE FUNCTION; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84901617284     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000007     Document Type: Article

References (36)

1. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007;68:812-819. (Pubitemid 46568532)
2. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872. (Pubitemid 43970103)
3. Dodel R, Csoti I, Ebersbach G, et al. Lewy body dementia and Parkinson's disease with dementia. J Neurol. 2008;255(suppl 5): 39-47.
4. Maetzler W, Reimold M, Liepelt I, et al. [11C]PIB binding in Parkinson's disease dementia. Neuroimage. 2008;39:1027-1033.
5. Gomperts SN, Rentz DM, Moran E, et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71:903-910.
6. Rowe CC, Ng S, Ackermann U, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68:1718-1725. (Pubitemid 46763260)
7. Edison P, Rowe CC, Rinne JO, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry. 2008;79:1331-1338.
8. Aarsland D, Litvan I, Salmon D, et al. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003;74:1215-1220.
9. Mondon K, Gochard A, Marque A, et al. Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia. J Neurol Neurosurg Psychiatry. 2007;78:738-741. (Pubitemid 46998848)
10. Downes JJ, Priestley NM, Doran M, et al. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease. Behav Neurol. 1998;11:173-183. (Pubitemid 29537556)
11. Noe E, Marder K, Bell KL, et al. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord. 2004;19:60-67. (Pubitemid 38559622)
12. Janvin CC, Larsen JP, Aarsland D, et al. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord. 2006;21:1343-1349. (Pubitemid 44613283)
13. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012; 27:349-356.
14. Jicha GA, Schmitt FA, Abner E, et al. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging. 2010;31:1805-1813.
15. Molano J, Boeve B, Ferman T, et al. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: A clinicopathological study. Brain. 2010;133:540-556.
16. Fujishiro H, Nakamura S, Kitazawa M, et al. Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy. J Neurol Sci. 2012;315:115-119.
17. Hughes AJ, Ben-Shlomo Y, Daniel SE, et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology. 1992;42: 1142-1146.
18. Walker MP, Ayre GA, Cummings JL, et al. The clinician assessment of fluctuation and the one day fluctuation assessment scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 2000;177:252-256.
19. Collerton D, Perry E, McKeith I. Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005;28:737-757; discussion 757-794. (Pubitemid 43372762)
20. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314. (Pubitemid 24382728)
21. Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co.; 2003.
22. Song SK, Lee JE, Park HJ, et al. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord. 2011;26: 289-296.
23. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308. (Pubitemid 29120227)
24. Cho H, Yang DW, Shon YM, et al. Abnormal integrity of corticocortical tracts in mild cognitive impairment: A diffusion tensor imaging study. J Korean Med Sci. 2008;23:477-483.
25. Choi SH, Na DL, Lee BH, et al. Estimating the validity of the Korean version of expanded Clinical Dementia Rating (CDR) scale. J Korean Neurol Assoc. 2001;19:585-591.
26. Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia. Mov Disord. 2009;24:1740-1746.
27. Parkkinen L, Pirttila T, Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol. 2008;115:399-407.
28. Gomperts SN, Locascio JJ, Marquie M, et al. Brain amyloid and cognition in Lewy body diseases. Mov Disord. 2012; 27:965-973.
29. Petrou M, Bohnen NI, Muller ML, et al. Abeta-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 2012;79:1161-1167.
30. Gomperts SN, Locascio JJ, Rentz D, et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 2013;80:85-91.
31. Auning E, Rongve A, Fladby T, et al. Early and presenting symptoms of dementia with lewy bodies. Dement Geriatr Cogn Disord. 2011;32:202-208.
32. Lee JE, Park HJ, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxelbased diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2010;81:320-326.
33. Park KW, Kim HS, Cheon SM, et al. Dementia with Lewy bodies versus Alzheimer's disease and Parkinson's disease dementia: A comparison of cognitive profiles. J Clin Neurol. 2011;7:19-24.
34. Tam CW, Burton EJ, McKeith IG, et al. Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology. 2005;64:861-865. (Pubitemid 40316326)
35. Beyer MK, Larsen JP, Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology. 2007;69:747-754. (Pubitemid 47300931)
36. Walker Z, Jaros E, Walker RW, et al. Dementia with Lewy bodies: A comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry. 2007;78:1176-1181. (Pubitemid 350057277)